Telix Advances Development of Glioblastoma Therapy Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. CHWY
4. SPCX
5. USO
6. NAVN
7. HUMA
8. cASY
9. CME
10. OXM

Go back to Telix Advances Development of Glioblastoma Therapy Program
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.42 -0.02 (0.21%)
Previous Close $9.44    52 Week High $2.18 
Open $9.42    52 Week Low $0.30 
Day High $9.54    P/E N/A 
Day Low $9.34    EPS $-3.32 
Volume 57,190